Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Y Jeng

Showing results (51-60 of 100) with videos related to

Pageof 10
Sort By:
The Journal of Biological Chemistry|June 6, 1997
Suppression of substance P biosynthesis in sensory neurons of dorsal root ganglion by prodrug esters of potent peptidylglycine alpha-amidating monooxygenase inhibitorsA Y Jeng, R A Fujimoto, M Chou, et al.
Journal of Cardiovascular Pharmacology|May 22, 1998
Characterization of CGS 31447, a potent and nonpeptidic endothelin-converting enzyme inhibitorS S Shetty, P Savage, D DelGrande, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1989
Effects of adenosine A2 receptor agonists on nucleoside transportJ L Balwierczak, C M Krulan, Z C Wang, et al.
Ciba Foundation Symposium|January 1, 1985
Receptors for the phorbol ester tumour promotersP M Blumberg, K L Leach, B König, et al.
Cancer Research|August 15, 1988
Contrasting actions of staurosporine, a protein kinase C inhibitor, on human neutrophils and primary mouse epidermal cellsT Sako, A I Tauber, A Y Jeng, et al.
Analytical Biochemistry|March 1, 1990
A radioimmunoassay for measuring alpha-amidating enzyme activityA Y Jeng, M Wong, S J Lovato, et al.
Journal of Cardiovascular Pharmacology|May 22, 1998
Benzofused macrocyclic lactams as triple inhibitors of endothelin-converting enzyme, neutral endopeptidase 24.11, and angiotensin-converting enzymeG M Ksander, P Savage, A J Trapani, et al.
Biochemistry International|September 1, 1992
Decrease in immunoreactivity and vasoactivity of endothelin-1 after exposure to oxygenJ L Balwierczak, M F Hopkins, P Savage, et al.
Neuroscience|July 3, 1999
Endothelin converting enzyme-1-, endothelin-1-, and endothelin-3-like immunoreactivity in the rat brainJ M Sluck, R C Lin, L I Katolik, et al.
Journal of Cardiovascular Pharmacology|November 15, 2000
Pharmacological properties of CGS 35066, a potent and selective endothelin-converting enzyme inhibitor, in conscious ratsA J Trapani, M E Beil, C W Bruseo, et al.
Pageof 10

Showing results (51-60 of 100) with videos related to

Sort By:
Pageof 10
The Journal of Biological Chemistry|June 6, 1997
Suppression of substance P biosynthesis in sensory neurons of dorsal root ganglion by prodrug esters of potent peptidylglycine alpha-amidating monooxygenase inhibitorsA Y Jeng, R A Fujimoto, M Chou, et al.
Journal of Cardiovascular Pharmacology|May 22, 1998
Characterization of CGS 31447, a potent and nonpeptidic endothelin-converting enzyme inhibitorS S Shetty, P Savage, D DelGrande, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1989
Effects of adenosine A2 receptor agonists on nucleoside transportJ L Balwierczak, C M Krulan, Z C Wang, et al.
Ciba Foundation Symposium|January 1, 1985
Receptors for the phorbol ester tumour promotersP M Blumberg, K L Leach, B König, et al.
Cancer Research|August 15, 1988
Contrasting actions of staurosporine, a protein kinase C inhibitor, on human neutrophils and primary mouse epidermal cellsT Sako, A I Tauber, A Y Jeng, et al.
Analytical Biochemistry|March 1, 1990
A radioimmunoassay for measuring alpha-amidating enzyme activityA Y Jeng, M Wong, S J Lovato, et al.
Journal of Cardiovascular Pharmacology|May 22, 1998
Benzofused macrocyclic lactams as triple inhibitors of endothelin-converting enzyme, neutral endopeptidase 24.11, and angiotensin-converting enzymeG M Ksander, P Savage, A J Trapani, et al.
Biochemistry International|September 1, 1992
Decrease in immunoreactivity and vasoactivity of endothelin-1 after exposure to oxygenJ L Balwierczak, M F Hopkins, P Savage, et al.
Neuroscience|July 3, 1999
Endothelin converting enzyme-1-, endothelin-1-, and endothelin-3-like immunoreactivity in the rat brainJ M Sluck, R C Lin, L I Katolik, et al.
Journal of Cardiovascular Pharmacology|November 15, 2000
Pharmacological properties of CGS 35066, a potent and selective endothelin-converting enzyme inhibitor, in conscious ratsA J Trapani, M E Beil, C W Bruseo, et al.
Pageof 10